Bharat Biotech in a statement on Wednesday said Covaxin vaccine demonstrated 81 per cent interim efficacy in preventing Covid-19 after a third round of clinical trials.
Sign in
Welcome! Log into your account
Forgot your password? Get help
Password recovery
Recover your password
A password will be e-mailed to you.